Germany's new reimbursement fee schedule for laboratory tests hits diagnostics industry
This article was originally published in Clinica
Germany's new fee scale for reimbursing laboratory tests is having a negative impact on the country's declining laboratory diagnostics sector, says the German diagnostics manufacturers association, VDGH. The new regulations, introduced in July 1999, subject basic and special laboratory services to budgetary restraints which have to be followed by the prescribing doctor (see Clinica No 851, p 7).
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.